The European market for Platelet-Rich Plasma Market (PRP) therapy is anticipated to reach US$ 80.3 million by 2033, reflecting a steady growth trajectory. This represents a projected Compound Annual Growth Rate (CAGR) of 3.4% from a base valuation of US$ 57.5 million in 2023. Growing Patient Interest and Improved Treatment Experiences A growing emphasis on …